INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in AST SpaceMobile, Inc. to Contact Law Firm

Moore Law says it is investigating AST SpaceMobile after three reported stock declines following company or analyst news: shares fell 12.06% on Jan. 7 after Scotiabank downgraded the stock, 15.17% on Feb. 12 after a $1 billion convertible-notes offering, and 17.04% on July 16 after another $1 billion convertible senior-notes offering. The firm cites questions about competition, user adoption and financing, and is soliciting shareholders to contact it; the article reports no finding of wrongdoing or new market-moving company development.

Analysis

The investable issue is capital-allocation credibility, not the existence of a shareholder investigation. A law-firm solicitation is not evidence of liability, and its event-study framing does not establish that the cited news alone caused each share-price move. Still, repeated financing announcements after prior funding assurances can raise the equity risk premium: investors may discount future satellite milestones until management reconciles cash needs, deployment costs and any partnership or acquisition ambitions. Convertible financing can extend runway, but conversion terms and potential dilution matter; the supplied report does not provide enough detail to quantify either.

Near term (days to weeks), litigation headlines are likely secondary to financing terms and operating updates. Over 1–3 months, watch for filings, cash runway and capex guidance, satellite deployment milestones, and whether proposed partnerships become signed agreements. Over 6–18 months, adoption and reliable service delivery determine whether the competitive threat from Starlink is a valuation concern or a real share-of-market constraint. A counterpoint: if funding demonstrably covers the planned constellation and execution milestones arrive, the market may have over-penalized financing itself. Scotiabank is mentioned only as the source of a downgrade; this item supplies no material fundamental implication for BNS.

Key Decisions for Investors

• Do not trade the investigation headline in isolation. Before adding to ASTS, verify the latest cash balance/runway, convert coupon and conversion terms, planned capital spending, and whether management has changed its prior funding outlook.
• Near-term stance: avoid initiating an unhedged long ahead of the next financing or deployment update. Reassess after management provides a reconciled funding plan and measurable milestone dates; the thesis improves if guidance supports the plan without another unexpected capital raise.
• For investors already long, consider reducing position risk or using a defined-risk hedge only after checking current option pricing and liquidity. Do not assume the historical event-day declines will repeat; the article provides no current price or basis to set an entry level.
• Falsifiers: a further financing need or downward revision to deployment/adoption guidance would reinforce the credibility and dilution risk; a funded, on-schedule deployment plan plus signed commercial arrangements would weaken the bearish thesis.